BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8423028)

  • 1. Nuclear type II estradiol binding sites and type I estrogen receptors in human endometrial cancer: a 5-year follow-up study.
    Környei JL; Csermely T; Keller G; Vértes M
    Gynecol Oncol; 1993 Jan; 48(1):94-103. PubMed ID: 8423028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.
    Bayard F; Damilano S; Robel P; Baulieu EE
    J Clin Endocrinol Metab; 1978 Apr; 46(4):635-48. PubMed ID: 755048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical analysis of estrogen receptor and progesterone receptor in normal uterus and endometrial carcinoma].
    Saito N
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):87-101. PubMed ID: 3569607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor.
    Ferrandina G; Scambia G; Benedetti Panici P; Ranelletti FO; De Vincenzo R; Piantelli M; Distefano M; Capelli A; Mancuso S
    Gynecol Oncol; 1993 Apr; 49(1):67-72. PubMed ID: 8482562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
    Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
    Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS).
    Ferrandina G; Ranelletti FO; Scambia G; Benedetti Panici P; D'Agostino G; Piantelli M; Isola G; Mancuso S
    Cancer Lett; 1995 Sep; 96(1):123-31. PubMed ID: 7553600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial progesterone and estradiol receptors in patients with recurrent early pregnancy loss of unknown etiology--preliminary report.
    Carranza-Lira S; Blanquet J; Tserotas K; Calzada L
    Med Sci Monit; 2000; 6(4):759-62. PubMed ID: 11208405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic estrogen and progesterone receptors in canine endometrium during the estrous cycle.
    Johnston SD; Kiang DT; Seguin BE; Hegstad RL
    Am J Vet Res; 1985 Aug; 46(8):1653-8. PubMed ID: 4041148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine estradiol and progesterone receptor concentration, activities of certain antioxidant enzymes and dehydrogenases and histoarchitecture in relation to time of secretion of nidatory estrogen and high endometrial sensitivity in rat.
    Singh MM; Trivedi RN; Chauhan SC; Srivastava VM; Makker A; Chowdhury SR; Kamboj VP
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):215-24. PubMed ID: 9010337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unoccupied nuclear receptors for estrogen in human endometrial tissue.
    Geier A; Beery R; Levran D; Menczer J; Lunenfeld B
    J Clin Endocrinol Metab; 1980 Mar; 50(3):541-5. PubMed ID: 7358834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.